FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034294242> ?p ?o ?g. }

• W2034294242 endingPage "337" @default.
• W2034294242 startingPage "331" @default.
• W2034294242 abstract "Breakthrough pain is a highly prevalent and difficult to manage cancer pain problem. Current strategies are frequently ineffective, in part because of a mismatch between the sudden onset and brief duration of breakthrough pain and the slower onset and more prolonged duration of oral immediate-release opioids. Novel analgesic interventions are needed to provide a closer match between the temporal profile of the pain and the pharmacodynamics of the pain medication, and novel models of study of breakthrough pain are needed to evaluate them.This is an open-label feasibility study of a model to evaluate sublingual methadone for cancer-related breakthrough pain. The model has three phases: screening, upward titration, and optimal dose evaluation.Seven patients with breakthrough pain because of cancer entered the upward titration phase of the trial, and 61 episodes of breakthrough pain were evaluated with sublingual methadone at escalating doses ranging from 2-18 mg. Toxicity was generally mild and similar to patients' prior breakthrough medication. Four patients entered the optimal dose evaluation phase, and 39 discrete episodes of breakthrough pain were available for evaluation. Significant relief of pain occurred with a median onset of 5 minutes, and no serious adverse events were encountered.This model of assessment of breakthrough pain, whereby each episode of pain is treated as a separate data set and multiple discrete episodes of breakthrough pain are assessed every 5 minutes in each patient, appears to be feasible within the cancer pain population. Preliminary results suggest a very rapid onset of relief of breakthrough pain with sublingual methadone when administered at the optimal dose, consistent with a highly favorable early pharmacodynamic profile of methadone administered via this route. Further study is warranted." @default.
• W2034294242 created "2016-06-24" @default.
• W2034294242 creator A5035832844 @default.
• W2034294242 creator A5038508305 @default.
• W2034294242 creator A5082309855 @default.
• W2034294242 date "2007-04-01" @default.
• W2034294242 modified "2023-10-16" @default.
• W2034294242 title "Sublingual Methadone for the Management of Cancer-Related Breakthrough Pain: A Pilot Study" @default.
• W2034294242 cites W161235706 @default.
• W2034294242 cites W174087362 @default.
• W2034294242 cites W1963668674 @default.
• W2034294242 cites W1967044871 @default.
• W2034294242 cites W1976427793 @default.
• W2034294242 cites W1990554427 @default.
• W2034294242 cites W1990596188 @default.
• W2034294242 cites W1999275813 @default.
• W2034294242 cites W2000801346 @default.
• W2034294242 cites W2001844000 @default.
• W2034294242 cites W2013187174 @default.
• W2034294242 cites W2023671892 @default.
• W2034294242 cites W2028233993 @default.
• W2034294242 cites W2030663116 @default.
• W2034294242 cites W2032968567 @default.
• W2034294242 cites W2036217399 @default.
• W2034294242 cites W2051429066 @default.
• W2034294242 cites W2053986063 @default.
• W2034294242 cites W2058784072 @default.
• W2034294242 cites W2064295454 @default.
• W2034294242 cites W2072255226 @default.
• W2034294242 cites W2075716831 @default.
• W2034294242 cites W2077139817 @default.
• W2034294242 cites W2088345020 @default.
• W2034294242 cites W2105343229 @default.
• W2034294242 doi "https://doi.org/10.1089/jpm.2006.0163" @default.
• W2034294242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17472503" @default.
• W2034294242 hasPublicationYear "2007" @default.
• W2034294242 type Work @default.
• W2034294242 sameAs 2034294242 @default.
• W2034294242 citedByCount "38" @default.
• W2034294242 countsByYear W20342942422012 @default.
• W2034294242 countsByYear W20342942422013 @default.
• W2034294242 countsByYear W20342942422014 @default.
• W2034294242 countsByYear W20342942422015 @default.
• W2034294242 countsByYear W20342942422016 @default.
• W2034294242 countsByYear W20342942422018 @default.
• W2034294242 countsByYear W20342942422019 @default.
• W2034294242 countsByYear W20342942422020 @default.
• W2034294242 countsByYear W20342942422022 @default.
• W2034294242 countsByYear W20342942422023 @default.
• W2034294242 crossrefType "journal-article" @default.
• W2034294242 hasAuthorship W2034294242A5035832844 @default.
• W2034294242 hasAuthorship W2034294242A5038508305 @default.
• W2034294242 hasAuthorship W2034294242A5082309855 @default.
• W2034294242 hasConcept C121608353 @default.
• W2034294242 hasConcept C126322002 @default.
• W2034294242 hasConcept C170493617 @default.
• W2034294242 hasConcept C197934379 @default.
• W2034294242 hasConcept C2778282284 @default.
• W2034294242 hasConcept C2778767360 @default.
• W2034294242 hasConcept C2778904085 @default.
• W2034294242 hasConcept C2780820201 @default.
• W2034294242 hasConcept C2781063702 @default.
• W2034294242 hasConcept C2908647359 @default.
• W2034294242 hasConcept C2909746581 @default.
• W2034294242 hasConcept C2983098980 @default.
• W2034294242 hasConcept C42219234 @default.
• W2034294242 hasConcept C71924100 @default.
• W2034294242 hasConcept C99454951 @default.
• W2034294242 hasConceptScore W2034294242C121608353 @default.
• W2034294242 hasConceptScore W2034294242C126322002 @default.
• W2034294242 hasConceptScore W2034294242C170493617 @default.
• W2034294242 hasConceptScore W2034294242C197934379 @default.
• W2034294242 hasConceptScore W2034294242C2778282284 @default.
• W2034294242 hasConceptScore W2034294242C2778767360 @default.
• W2034294242 hasConceptScore W2034294242C2778904085 @default.
• W2034294242 hasConceptScore W2034294242C2780820201 @default.
• W2034294242 hasConceptScore W2034294242C2781063702 @default.
• W2034294242 hasConceptScore W2034294242C2908647359 @default.
• W2034294242 hasConceptScore W2034294242C2909746581 @default.
• W2034294242 hasConceptScore W2034294242C2983098980 @default.
• W2034294242 hasConceptScore W2034294242C42219234 @default.
• W2034294242 hasConceptScore W2034294242C71924100 @default.
• W2034294242 hasConceptScore W2034294242C99454951 @default.
• W2034294242 hasIssue "2" @default.
• W2034294242 hasLocation W20342942421 @default.
• W2034294242 hasLocation W20342942422 @default.
• W2034294242 hasOpenAccess W2034294242 @default.
• W2034294242 hasPrimaryLocation W20342942421 @default.
• W2034294242 hasRelatedWork W1994576386 @default.
• W2034294242 hasRelatedWork W2000801346 @default.
• W2034294242 hasRelatedWork W2034294242 @default.
• W2034294242 hasRelatedWork W2037560904 @default.
• W2034294242 hasRelatedWork W2080593255 @default.
• W2034294242 hasRelatedWork W2330938710 @default.
• W2034294242 hasRelatedWork W2414972101 @default.
• W2034294242 hasRelatedWork W2969364905 @default.
• W2034294242 hasRelatedWork W3131049068 @default.
• W2034294242 hasRelatedWork W4295709187 @default.

• next